UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Heliximith unveiled how HX109 inhibits prostate hyperplasia
Heliximith said that HX109, its prostate hyperplasia (BPH) prevention and t...
by Lee Han-soo
|
2020-07-02 15:03
라인
MSD Korea reshuffles personnel before spinoff of Organon
MSD Korea has newly appointed key executives to lead each business unit bef...
by Kim Yun-mi
|
2020-07-02 13:44
라인
New virus cases remain above 50 for two days
Korea reported new Covid-19 cases of above 50 for two consecutive days on T...
by Lee Han-soo
|
2020-07-02 12:23
라인
‘Plasma therapy effective on Covid-19 despite blood type mismatch’
A paper titled, “Convalescent Plasma Therapy in Coronavirus Disease 2019: a...
by Song Soo-youn
|
2020-07-02 11:37
라인
GC LabCell wins Japanese patent for cryopreservation
GC LabCell said Wednesday that it has obtained a patent for a cell medium c...
by Shim Hyun-tai
|
2020-07-01 20:05
라인
Novartis’ asthma drug gets insurance benefit
Novartis’ allergic asthma and chronic urticarial drug Xolair (ingredient: o...
by Shim Hyun-tai
|
2020-07-01 20:05
라인
Takeda Korea completes takeover of Shire Korea
Takeda Pharmaceuticals Korea announced Wednesday that it has completed the ...
by Lee Han-soo
|
2020-07-01 17:39
라인
[Special] HIV patients pushed aside amid Covid-19 crisis
The Covid-19 pandemic prompted the public health authorities to concentrate...
by Kim Yun-mi
|
2020-07-01 16:18
라인
‘Pediatric patients marginalized from Covid-19 response measures’
The nation’s Covid-19 response system is excessively centered on adult pati...
by Song Soo-youn
|
2020-07-01 16:14
라인
Korea starts supplying remdesivir to local hospitals
The Korea Centers for Disease Control and Prevention (KCDC) said it would p...
by Lee Han-soo
|
2020-07-01 16:08
라인
Local infections shift from eastern to western regions
The epicenters of cluster infections in Korea have recently shifted to the ...
by Lee Han-soo
|
2020-07-01 14:19
라인
Hanmi to export dyslipidemia drug to Mexico via MSD
Hanmi Pharmaceutical said Wednesday that its partner, MSD, has obtained mar...
by Shim Hyun-tai
|
2020-07-01 14:19
라인
Covid-19 increases smartphone use, reduces drinking
The new coronavirus has made Korean people drink less alcohol but spend mor...
by Song Soo-youn
|
2020-07-01 11:55
라인
Huons to export KF94 masks to Washington state
Huons said Tuesday that it would export "Korea Filter 94" (KF94) face masks...
by Shim Hyun-tai
|
2020-06-30 18:23
라인
Mass food poisoning of children raises concerns about hamburger disease
Operators of a kindergarten in Ansan, Gyeonggi Province, have been under fi...
by Shim Hyun-tai
|
2020-06-30 17:41
라인
Hanmi's short bowel syndrome treatment wins rare pediatric disease status
The U.S. Food and Drug Administration has granted a rare pediatric disease ...
by Lee Han-soo
|
2020-06-30 17:38
라인
Chunlab launches new microbiome healthcare solution
Chunlab, a company specializing in the microbiome, launched a three-step pr...
by Shim Hyun-tai
|
2020-06-30 17:03
라인
Hugel submits NDA for BTX product in Europe
Hugel said that it has submitted a new drug application (NDA) in Europe for...
by Lee Han-soo
|
2020-06-30 15:36
라인
‘Non-contact patient care is safe and efficient’
Remote patient care amid the Covid-19 crisis minimized the risk of viral in...
by Choi Gwang-seok
|
2020-06-30 15:19
라인
NCC finds clue to immunotherapy of malignant brain tumors
Researchers at the National Cancer Center (NCC) said they have found a clue...
by Lee Han-soo
|
2020-06-30 14:52
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top